Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | $1.79B | $234.60M | -$10.65M | -$13.23M | -$0.46 | 157.01% | 25.62% | N/A | N/A | 2026-05-07 | ||
| ELTX | ELICIO THERAPEUTICS INC | $189.85M | $0.00 | -$37.31M | -$39.57M | -$2.58 | N/A | -100.00% | N/A | N/A | |||
| DSGX | DESCARTES SYSTEMS GROUP INC | $6.22B | $728.99M | $305.19M | $163.77M | $1.91 | 11.98% | 15.89% | 13.69% | 25.24% | 2026-06-03 | ||
| MGNX | MACROGENICS INC | $186.85M | $149.50M | -$57.83M | -$74.62M | -$1.18 | -0.31% | 7.35% | N/A | N/A | |||
| RAPP | RAPPORT THERAPEUTICS INC | $1.58B | $0.00 | -$108.43M | -$111.48M | -$2.86 | N/A | N/A | N/A | N/A | |||
| BLZE | BACKBLAZE INC | $241.19M | $145.84M | $8.87M | -$25.61M | -$0.46 | 14.27% | 22.08% | N/A | N/A | |||
| XNCR | XENCOR INC | $852.20M | $125.58M | -$46.98M | -$91.92M | -$1.24 | 13.65% | 0.47% | N/A | N/A | |||
| PCOR | PROCORE TECHNOLOGIES INC | $8.40B | $1.32B | $23.59M | -$100.78M | -$0.67 | 14.83% | 27.00% | N/A | N/A | |||
| ASST | STRIVE INC | $996.58M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-05-14 | ||
| PHAR | PHARMING GROUP NV | $1.15B | $437.37M | $28.35M | $3.32M | $0.05 | 42.94% | 11.33% | N/A | -41.85% | 2026-05-07 | ||
| EXOD | EXODUS MOVEMENT INC | $210.77M | $121.55M | -$16.33M | -$11.35M | -$0.39 | 4.54% | N/A | N/A | N/A | |||
| AGBK | AGI INC | $1.36B | $1.07B | $388.86M | $198.44M | $0.24 | 40.37% | N/A | 38.27% | N/A | 2026-05-05 | ||
| TRVI | TREVI THERAPEUTICS INC | $1.77B | $0.00 | -$42.68M | -$42.76M | -$0.32 | N/A | N/A | N/A | N/A | |||
| CABA | CABALETTA BIO INC | $309.48M | $0.00 | -$148.84M | -$167.86M | -$2.10 | N/A | N/A | N/A | N/A | 2026-05-20 | ||
| WALD | WALDENCAST PLC | $97.85M | $272.07M | -$157.56M | -$229.75M | -$2.01 | -0.66% | 23.57% | N/A | N/A | 2026-05-26 | ||
| AGMB | AGOMAB THERAPEUTICS NV | $523.43M | $0.00 | -$72.32M | -$72.73M | -$166.54 | N/A | N/A | N/A | N/A | |||
| IRON | DISC MEDICINE INC | $2.52B | $0.00 | -$207.46M | -$212.18M | -$6.01 | N/A | N/A | N/A | N/A | 2026-05-07 | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.88B | $1.09B | $338.91M | $202.27M | $1.56 | 43,539.24% | 68.70% | N/A | N/A | |||
| DMRA | DAMORA THERAPEUTICS INC | $1.44B | $0.00 | -$209.76M | -$209.84M | $3.98 | N/A | N/A | N/A | N/A | |||
| TLX | TELIX PHARMACEUTICALS LTD | $3.53B | $558.19M | $24.72M | -$4.95M | N/A | 68.14% | N/A | N/A | N/A | |||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.32B | $0.00 | -$364.13M | -$377.94M | -$3.29 | N/A | -100.00% | N/A | N/A | 2026-05-07 | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $147.23M | $70.00M | $22.69M | $22.37M | $0.39 | N/A | N/A | N/A | N/A | 2026-05-13 | ||
| ERAS | ERASCA INC | $2.83B | $0.00 | -$121.44M | -$124.55M | -$0.44 | N/A | N/A | N/A | N/A | 2026-05-07 | ||
| MGPI | MGP INGREDIENTS INC | $409.47M | $521.15M | -$241.49M | -$238.36M | -$11.15 | -20.40% | 5.18% | N/A | N/A | |||
| CPS | COOPER-STANDARD HOLDINGS INC | $511.47M | $2.74B | $189.28M | -$4.17M | -$0.23 | 0.37% | 2.90% | N/A | N/A | 2026-04-30 | ||
| BLSH | BULLISH | $5.51B | $244.96B | -$750.01M | -$806.26M | -$5.99 | -2.11% | N/A | N/A | N/A | 2026-06-03 | ||
| DC | DAKOTA GOLD CORP | $707.64M | $0.00 | -$29.40M | -$29.54M | -$0.27 | N/A | N/A | N/A | N/A | 2026-06-03 | ||
| BIOA | BIOAGE LABS INC | $748.24M | $9.00M | -$79.57M | -$80.61M | -$2.24 | N/A | N/A | N/A | N/A | 2026-05-12 | ||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $207.94M | $0.00 | -$99.39M | -$101.70M | -$1.90 | N/A | -100.00% | N/A | N/A | |||
| ARVN | ARVINAS INC | $628.10M | $262.60M | -$75.30M | -$80.80M | -$1.14 | -0.30% | 58.93% | N/A | N/A | |||
| PEPG | PEPGEN INC | $107.13M | $0.00 | -$88.21M | -$89.66M | -$2.12 | N/A | N/A | N/A | N/A | 2026-05-07 | ||
| DEFT | DEFI TECHNOLOGIES INC | $290.91M | $71.84M | $49.99M | $45.22M | $0.13 | 231.58% | 99.07% | N/A | 33.41% | |||
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $2.10B | $83.21M | N/A | -$180.11M | -$2.02 | -39.29% | N/A | N/A | N/A | |||
| RLMD | RELMADA THERAPEUTICS INC | $773.04M | $0.00 | -$57.39M | -$57.39M | -$1.45 | N/A | N/A | N/A | N/A | 2026-05-13 | ||
| PERI | PERION NETWORK LTD | $400.79M | $439.93M | $12.70M | -$7.93M | -$0.19 | -11.71% | 6.04% | N/A | N/A | 2026-05-13 | ||
| IPX | IPERIONX LTD | $977.02M | $0.00 | N/A | -$53.88M | -$1.60 | N/A | N/A | N/A | N/A | 2026-06-03 | ||
| KWR | QUAKER CHEMICAL CORP | $2.31B | $1.89B | $159.62M | -$2.49M | -$0.14 | 2.66% | 5.90% | N/A | N/A | 2026-04-30 | ||
| CNTX | CONTEXT THERAPEUTICS INC | $215.00M | $0.00 | -$36.00M | -$36.12M | -$0.38 | N/A | N/A | N/A | N/A | 2026-05-13 | ||
| ABVX | ABIVAX SA | $8.34B | $5.25M | -$249.93M | -$386.32M | -$5.55 | -58.54% | N/A | N/A | N/A | |||
| BILL | BILL HOLDINGS INC | $3.69B | $1.55B | $92.12M | -$24.21M | -$0.24 | 11.84% | 53.25% | N/A | N/A | 2026-04-30 | ||
| TYRA | TYRA BIOSCIENCES INC | $1.82B | $0.00 | -$119.40M | -$119.95M | -$2.01 | N/A | N/A | N/A | N/A | 2026-04-30 | ||
| ELAN | ELANCO ANIMAL HEALTH INC | $10.84B | $4.72B | $676.00M | -$232.00M | -$0.47 | 6.22% | 7.59% | N/A | N/A | 2026-05-13 | ||
| WPM | WHEATON PRECIOUS METALS CORP | $56.70B | $2.31B | $2.01B | $1.47B | $3.24 | 80.18% | 16.12% | 177.81% | 23.42% | |||
| DCGO | DOCGO INC | $69.82M | $322.20M | -$156.63M | -$182.40M | -$1.84 | -47.74% | 27.91% | N/A | N/A | 2026-05-11 | ||
| MARA | MARA HOLDINGS INC | $4.08B | $907.09M | -$546.71M | -$1.31B | -$3.69 | 38.20% | 190.87% | N/A | N/A | 2026-05-07 | ||
| CLFD | CLEARFIELD INC | $381.96M | $149.00M | $1.82M | -$6.76M | -$0.49 | 23.10% | 8.13% | N/A | N/A | |||
| NKTX | NKARTA INC | $191.77M | $0.00 | -$92.94M | -$104.08M | -$1.41 | N/A | N/A | N/A | N/A | |||
| LTM | LATAM AIRLINES GROUP SA | $26.94B | $14.27B | $2.34B | $1.46B | $4.95 | 11.16% | 29.45% | 53.28% | N/A | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $207.69M | $364.78M | $102.58M | $25.04M | $0.84 | -0.19% | 11.47% | -17.65% | 83.84% | |||
| MMED | MINIMED GROUP INC | $3.38B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-06-03 | ||
| LBRX | LB PHARMACEUTICALS INC | $877.16M | $0.00 | -$24.74M | -$25.21M | -$3.13 | N/A | N/A | N/A | N/A | 2026-05-15 | ||
| KRRO | KORRO BIO INC | $181.87M | $6.39M | -$111.61M | -$117.26M | -$12.48 | 181.46% | -29.61% | N/A | N/A | |||
| SLDB | SOLID BIOSCIENCES INC | $693.66M | $0.00 | -$170.52M | -$174.33M | -$1.99 | N/A | N/A | N/A | N/A | |||
| PCVX | VAXCYTE INC | $8.25B | $0.00 | -$741.77M | -$766.63M | -$5.63 | N/A | N/A | N/A | N/A | |||
| CGEM | CULLINAN THERAPEUTICS INC | $777.76M | $0.00 | -$219.57M | -$220.56M | -$3.36 | N/A | N/A | N/A | N/A | |||
| CGTX | COGNITION THERAPEUTICS INC | $105.44M | $0.00 | -$23.25M | -$23.49M | -$0.32 | N/A | N/A | N/A | N/A | |||
| CRVO | CERVOMED INC | $33.79M | $4.01M | -$26.97M | -$26.97M | -$2.98 | -58.86% | N/A | N/A | N/A | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $447.76M | $884.00k | -$100.29M | -$103.12M | -$1.40 | -39.20% | -38.32% | N/A | N/A | 2026-05-19 | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $449.76M | $85.21M | -$132.48M | -$140.11M | -$2.42 | 230,194.59% | 44.32% | N/A | N/A | 2026-05-07 | ||
| KYMR | KYMERA THERAPEUTICS INC | $6.65B | $39.21M | -$302.67M | -$311.35M | -$3.69 | -16.70% | 2.87% | N/A | N/A | 2026-04-30 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.